Work

S1637 Ustekinumab vs Vedolizumab and Ustekinumab vs Tumor Necrosis Factor Alpha Agent Infectious Adverse Effects in Patients With Ulcerative Colitis: A Short Report Based on Real-World Data

Year: 2025

Type: conference-abstract

Source: The American Journal of Gastroenterology

DOI: 10.14309/01.ajg.0001134008.79233.c4

Authors: Hussam Almasri, Abdellatif Ismail, Guneet Sidhu, Himsikhar Khataniar, Muhammad Ali Butt, Rahul Karna, John Bassett, Daphne Moutsoglou

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417166044

Cites:

Cited by:

Related to: